Adore Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 20-06-2024
- Paid Up Capital ₹ 1.00 M
as on 20-06-2024
- Company Age 39 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.80 M
as on 20-06-2024
- Satisfied Charges ₹ 2.69 M
as on 20-06-2024
- Revenue 24.46%
(FY 2022)
- Profit 44.76%
(FY 2022)
- Ebitda 42.07%
(FY 2022)
- Net Worth 5.04%
(FY 2022)
- Total Assets 16.43%
(FY 2022)
About Adore Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.80 M. The company has closed loans amounting to ₹2.69 M, as per Ministry of Corporate Affairs (MCA) records.
Samir Sheth, Sachin Doshi, and Meeta Sheth serve as directors at the Company.
- CIN/LLPIN
U24230MH1985PTC035071
- Company No.
035071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 1985
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Adore Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Sheth  | Director | 15-Jan-1985 | Current |
| Sachin Doshi | Director | 15-Jan-1985 | Current |
| Meeta Sheth | Director | 01-Feb-2021 | Current |
Financial Performance of Adore Pharmaceuticals.
Adore Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 24.46% increase. The company also saw a substantial improvement in profitability, with a 44.76% increase in profit. The company's net worth moved up by a moderate rise of 5.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adore Pharmaceuticals?
Unlock access to Adore Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Noetic Finance Private LimitedActive 33 years 3 monthsSamir Sheth and Sachin Doshi are mutual person
- Perpetual Growth Investments Private LimitedActive 30 years 2 months
Sachin Doshi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Nov 1992 | ₹4.80 M | Open |
State Bank Of India Creation Date: 08 May 1987 | ₹2.69 M | Satisfied |
How Many Employees Work at Adore Pharmaceuticals?
Adore Pharmaceuticals has a workforce of 45 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adore Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
